In the pathogenesis and progression of NASH, the CD4 T cell is biased toward Th1 and Th17 phenotypes and promotes steatosis and inflammation [60,61,62]. The gene discussed is CD4; the disease is metabolic dysfunction-associated steatohepatitis.